NATURE’S SUNSHINE PRODUCTS, INC. Gain (Loss) on Sale of Properties
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Gain (Loss) on Sale of Properties of $0 for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfProperties · last filed 2018-05-10
- NATURE’S SUNSHINE PRODUCTS, INC. gain (loss) on sale of properties for the quarter ending 2018-03-31 was $0.00.
| Period end | Gain (Loss) on Sale of Properties 3 month |
|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |